Background: Diagnostic outcomes in eating disorder (ED) risk reduction trials are important but
program that has been found to significantly reduce a range of ED (and obesity) risk factors in young-adolescent girls and boys (Wilksch & Wade, 2009; Wilksch, Paxton, Byrne, Austin, and McLean, 2015) , significantly reduce growth in girls' shape and weight concerns over a 2.5-year follow-up (Wilksch & Wade, 2009) , and halve the rate of onset of clinically-significant shape and weight concerns at 12-month follow-up (Wilksch et al., 2015) . This online intervention was not moderated, so it was different form previous targeted prevention trials shown to decrease EDs; most of the previous trials were conducted at university sites with monitoring from a therapist moderator (e.g., Taylor et al., 2006) , or conducted face-to-face (Stice et al., 2008) . While the school version of Media Smart is a universal program (e.g., all girls and boys in school classes included regardless of baseline levels of ED risk), MS-T was developed as a targeted (i.e., 'indicated') program (e.g., participants included due to elevated baseline ED risk or already reporting disordered eating behaviors). Other targeted trials have understandably excluded those meeting ED diagnosis at baseline (Stice et al., 2008; Taylor et al., 2006) , while some have also excluded those meeting subclinical ED diagnosis or having previously accessed ED treatment (Taylor et al., 2006) .
A recent two-country randomized controlled trial (RCT; N 5 575)
of MS-T focused on outcomes related to measures of continuous disordered eating (global EDE-Q score), ED risk factors, and presence/ absence of disordered eating over a 12-month follow-up (Wilksch, O'Shea, Taylor, Wilfley, & Jacobi, 2017) . This trial was pragmatic in nature, meaning we sought to evaluate how the program would be used and its effectiveness under real-world conditions; at-scale across two countries with minimal exclusion criteria (Ford & Norrie, 2016) . Individuals self-referred based on wishing to improve body image, where the only exclusion criteria were: elevated suicide risk; alcohol or substance abuse; or, self-reported BMI < 15.0. At baseline, 76% of the sample met criteria for disordered eating, defined as having a global EDE-Q score 1 SD of the community mean (i.e., M 5 2.46: Mond, Hay, Rodgers, Owen, & Beumont, 2004) , in addition to a minimum of one of the following in the previous 4 weeks: fasting; vomiting; or laxatives to control weight; objective binge-eating episode; or BMI <18.5.
Despite this high proportion of eating pathology, just 14.7% of the sample endorsed having received treatment in the last 12 months for ED symptoms. As such, one of the strengths of this trial was the inclusion of many young women who were experiencing eating pathology who were not currently receiving care for these symptoms.
Analyses were conducted in two ways (Wilksch et al., 2017) :
Intention-to-treat (ITT); and, 'measure completers', referring to the 78% of the sample who completed who completed baseline and a minimum of one other assessment point. ITT analyses revealed MS-T participants had significantly higher quality of life-mental relative to controls, while amongst measure completers MS-T scored significantly lower than controls on: EDE-Q global; media internalization; depressive symptoms; ineffectiveness; and, clinical impairment. Of those with baseline DE, MS-T participants were significantly less likely than controls to still have disordered eating at 12-month follow-up. While program completion rates were low (13.6%), 41.2% (26/63) of those who completed the first module completed all modules.
The aims of this research were to investigate the efficacy of MS-T with regard to clinical (or diagnostic) outcomes-namely prevention effects (outcomes for those who did not meet ED diagnosis at baseline) and treatment effects (outcomes for those who met ED diagnosis at baseline). This responds to the calls for ED prevention scientists to give greater attention to the assessment and reporting of clinical outcomes in risk reduction trials (Becker, 2015) .
| M ET HOD

| Participants
Full information regarding recruitment, randomization and procedures appears in a separate report (Wilksch et al., 2017) . In brief, eligible participants were young-adult women (18-25 years) seeking to improve their body image from across Australia and New Zealand. Self-referral was used with sources including: flyers at universities (n 5 100; 31.9%); social media (n 5 87; 27.8%); and media reports (n 5 60;
19.2%).
| Program and procedure
A full description of the 9-module MS-T program has been reported (Wilksch et al., 2017) . Program content addresses prospectively identified ED risk factors (e.g., media internalization). Modules were released weekly and participants were encouraged to view interactive content, provide responses to questions, and complete homework assignments.
While MS-T was developed based on Media Smart (8-lesson school version), content was changed considerably to be appropriate for a youngadult, online, female-only audience. New content included a greater focus on social media pressures; emotion regulation; goal setting and a module to address eating-related risk factors was included (e.g., the importance of eating breakfast and regular eating). Consistent with other targeted trials, control participants received a one-off email providing tips for positive body image (e.g., Stice et al., 2008) .
| Procedure
The study website provided participants with information, consent procedures, and baseline questionnaires. Following questionnaire completion, the website automatically randomized participants to condition with MS-T participants were able to access their website immediately.
Automated email reminders were sent to all participants to complete post-program measures 10-weeks after baseline and at 6-and 12-month follow-up. A $AUD50 gift voucher was sent to participants who completed a minimum of three waves of assessment. Ethics approval for this research was received from the Flinders University Social and Behavioural Research Ethics Committee.
| Measures
ED diagnosis was assessed using the Eating Disorder Examination Questionnaire (EDE-Q: see Table 1 ). A systematic review concluded there was "data to support the ability of scores on the EDE-Q to While the interview is superior with respect to diagnosis, the EDE-Q has been used to generate diagnosis in a young-adult Australian outpatient sample (Mancuso, Newton, Bosanac, Rossell, & Nesci, 2015) and use of the EDE-Q was well-suited to the pragmatic approach to this research.
| Statistical analyses
The baseline frequencies of ED cases between conditions were investigated using v 2 analyses. Both prevention and treatment outcomes were investigated for those who completed measures at 12-month follow-up (N 5 205; 64.8% of baseline sample). Odds ratios (OR) and 95% CI from logistic regressions were used to compare diagnostic status at 12-month follow-up for MS-T participants relative to controls. These analyses were also conducted adjusting for receiving face-to-face treatment (e.g., psychologist, psychiatrist) at any point in the trial. 
| Prevention effects
Of the participants with 12-month follow-up data, n 5 15 met ED criteria who did not meet ED at baseline (n 5 66). Table 2 shows that MS-T participants were 66% less likely than controls to develop an ED by 12-month follow-up. Amongst those who did not seek external treatment during the trial, MS-T participants were 52% less likely than controls to meet ED diagnosis at 12-month follow-up. These results were not significant.
| Treatment effects
Of the participants with 12-month follow-up data, n 5 37 participants no longer met ED criteria who did meet criteria at baseline (n 5 117). Table 2 shows MS-T participants were 75% less likely than controls to meet ED criteria at 12-month follow-up. This finding was also significant amongst both nontreatment seekers and treatment seekers, where MS-T participants were 71% and 86% less respectively than their controls to meet diagnosis at 12-month follow-up.
To investigate this further, logistic regressions were run separately by ED diagnoses. A significant treatment effect was found for OSFED cases (OR 5 0.37, 95% CI [0.14-0.98]), where MS-T participants (17/27:63.0%) were 63% less likely than controls (19/49:
38.8%) to meet diagnosis at follow-up. This finding was also significant for those participants who did not access external face-to-face treatment during the trial cases (OR 5 0.32, 95% CI [0.11-0.95]).
Due to low numbers, AN, BN, and BED were combined to form one omnibus outcome. Of these cases, a higher proportion of MS-T participants (10/15: 66.6%) no longer met diagnosis at 12-month 
| D I SCUSSION
This trial investigated the impact of MS-T on ED diagnosis onset and remission in an online pragmatic RCT involving a community sample of self-referred young-adult women wishing to improve their body image.
Minimal exclusion criteria were used. Two key findings emerged. First, a treatment effect was found where MS-T significantly reduced the likelihood of continuing to meet diagnosis at 12-month follow-up. This was observed both for those who did, and did not, seek external faceto-face ED treatment. This finding extends the original RCT report, which also found a treatment effect for participants meeting more broad disordered eating criteria (Wilksch et al., 2017) . Post-hoc analyses revealed a significant effect specifically for OSFED cases, which might be related to the higher frequency of these cases compared to AN, BN and BED. Further, while OSFED causes significant suffering in its own right, it is possible that MS-T prevented a proportion of these cases from 'progressing' to one of the other diagnoses. To achieve this without participants requiring face-to-face treatment is a promising finding that warrants further investigation.
To the best of our knowledge, this was the first time a targeted program has resulted in a significant treatment effect using diagnostic outcomes. Some previous studies have achieved reductions in disordered eating behaviors in participants with subthreshold eating disorder symptoms, but excluded those meeting full syndrome diagnoses (Jacobi, V€ olker, Trockel, & Taylor, 2012; Saekow, Jones, Gibbs, Jacobi, & Fitzsimmons-Craft, 2015 Second, while not significant, MS-T participants were two thirds less likely than controls to become a new ED case by 12-month followup. This finding is encouraging and similar to that found for face-toface delivery of Healthy Weight (61%) and The Body Project (60%), though these findings were based on interview over a 2-3-year followup (Stice et al., 2008) . This lack of significance is likely due to the comparatively small proportion of participants who did not meet ED criteria at baseline. Given MS-T was originally developed as a targeted risk reduction program, it would be valuable for furture research to focus on recruiting a non-clinical sample to more fully assess MS-T's impact as a prevention program.
The limitations of this research have been previously outlined (Wilksch et al., 2017) . Of relevance to this report includes: the use of self-report rather than interview to assess ED symptoms; the 28-day time frame of EDE-Q assessment rather than the 3-month timeframe used with the EDE; and, measure completion rates being lower than other targeted prevention trials where this was exacerbated by use of online self-report assessment. Power analyses were conducted for continuous outcomes reported in the primary RCT (Wilksch et al., 2017) , thus findings for dichotomous outcomes presented need to be interpreted with caution and require replication.
While replication trials are required, MS-T holds promise as a program that to date has been found to: reduce ED onset by two thirds; be effective at significantly reducing eating pathology for those with baseline ED symptoms; and, which seems to augment rather than confound external treatment. Given the low implementation costs of MS-T where it is of a 'pure' self-help nature with fully automated registration and access procedures, the program has potential to be delivered atscale to assist those where face-to-face services are limited (e.g., long waiting lists), not available (e.g., remote areas), or where individuals are reluctant to attend face-to-face services. At the population level, this is likely to be a vast number of people where currently only a fraction are receiving the help that they need. Finally, it is of interest that while
Media Smart and MS-T sit at opposite ends of the prevention spectrum 
